These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31360890)

  • 1. A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.
    Xie W; Halabi S; Tierney JF; Sydes MR; Collette L; Dignam JJ; Buyse M; Sweeney CJ; Regan MM
    JNCI Cancer Spectr; 2019 Mar; 3(1):pkz002. PubMed ID: 31360890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses.
    Zhang J; Liang W; Liang H; Wang X; He J
    Ann Transl Med; 2019 Jun; 7(11):244. PubMed ID: 31317014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review.
    Savina M; Gourgou S; Italiano A; Dinart D; Rondeau V; Penel N; Mathoulin-Pelissier S; Bellera C
    Crit Rev Oncol Hematol; 2018 Mar; 123():21-41. PubMed ID: 29482777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review.
    Belin L; Tan A; De Rycke Y; Dechartres A
    Br J Cancer; 2020 May; 122(11):1707-1714. PubMed ID: 32214230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome?
    Bordewijk EM; Wang R; van Wely M; Costello MF; Norman RJ; Teede H; Gurrin LC; Mol BW; Li W
    Hum Reprod Update; 2020 Nov; 26(6):929-941. PubMed ID: 32935841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
    Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
    BMC Cancer; 2019 Jan; 19(1):56. PubMed ID: 30634944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reflection on the causal interpretation of individual-level surrogacy.
    Alonso A; Van Der Elst W; Molenberghs G; Florez AJ
    J Biopharm Stat; 2019; 29(3):529-540. PubMed ID: 30773114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study.
    Gao Y; Shi S; Li M; Luo X; Liu M; Yang K; Zhang J; Song F; Tian J
    BMC Med; 2020 Jun; 18(1):120. PubMed ID: 32475340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate end points for overall survival in breast cancer trials: A review.
    Fiteni F; Bonnetain F
    Breast; 2016 Oct; 29():44-8. PubMed ID: 27400447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).
    Lassere MN; Johnson KR; Schiff M; Rees D
    BMC Med Res Methodol; 2012 Mar; 12():27. PubMed ID: 22409774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials.
    Rotolo F; Paoletti X; Michiels S
    Comput Methods Programs Biomed; 2018 Mar; 155():189-198. PubMed ID: 29512498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new and rapid scoring system to assess the scientific evidence from clinical trials.
    Silber S
    J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance With Preferred Reporting Items for Systematic Review and Meta-Analysis Individual Participant Data Statement for Meta-Analyses Published for Stroke Studies.
    Jumah F; Chotai S; Ashraf O; Rallo MS; Raju B; Gadhiya A; Sun H; Narayan V; Gupta G; Nanda A
    Stroke; 2021 Aug; 52(9):2817-2826. PubMed ID: 34082573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity.
    Guo X; Bourgeois FT; Cai T
    Stat Methods Med Res; 2024 Jul; 33(7):1152-1162. PubMed ID: 38717356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.
    Tsujimoto Y; Fujii T; Onishi A; Omae K; Luo Y; Imai H; Takahashi S; Itaya T; Pinson C; Nevitt SJ; Furukawa TA
    J Clin Epidemiol; 2020 Feb; 118():107-114.e5. PubMed ID: 31654789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints.
    Lassere MN
    Stat Methods Med Res; 2008 Jun; 17(3):303-40. PubMed ID: 17925313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of individual participant data meta-analyses: A review of current practice.
    Simmonds M; Stewart G; Stewart L
    Contemp Clin Trials; 2015 Nov; 45(Pt A):76-83. PubMed ID: 26091948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.